Pegylated interferon alfa-2a and ribavirin

DRUG7 trials

Sponsors

National Taiwan University Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, Sociedad Andaluza de Enfermedades Infecciosas, Göteborg University, Beijing Ditan Hospital

Conditions

Chronic Hepatitis CGenotypeHIV InfectionHIV InfectionsHemodialysisHepatitis C VirusHepatitis C, ChronicLiver Cirrhosis

Phase 2

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

CompletedNCT01006031

Sociedad Andaluza de Enfermedades InfecciosasHepatitis C Virus, HIV Infection, Liver Cirrhosis

Start: 2009-10-31End: 2011-12-31Updated: 2011-12-30

Phase 4

Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin

CompletedNCT00491179

National Taiwan University HospitalChronic Hepatitis C, Hemodialysis

Start: 2006-06-30End: 2008-07-31Updated: 2009-11-13

Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C

CompletedNCT00540345

Kaohsiung Medical University Chung-Ho Memorial HospitalChronic Hepatitis C

Start: 2006-10-31End: 2013-12-31Updated: 2014-12-30

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

CompletedNCT00553930

Sociedad Andaluza de Enfermedades InfecciosasHepatitis C, Chronic, HIV Infections

Start: 2007-11-30End: 2010-05-31Target: 71Updated: 2010-05-18

A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

CompletedNCT00629967

Kaohsiung Medical University Chung-Ho Memorial HospitalChronic Hepatitis C, Genotype

Start: 2005-04-30End: 2007-05-31Updated: 2008-03-06

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin

TerminatedNCT00641654

Göteborg UniversityChronic Hepatitis C

Start: 2007-01-31End: 2009-12-31Updated: 2012-08-30

Unknown Phase

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

CompletedNCT01464008

Beijing Ditan HospitalChronic Hepatitis C

Start: 2004-01-31End: 2011-09-30Updated: 2016-09-27

Related Papers

Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients.

2012-01-035 citations